| cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
| NM_139312.1 | .a | 1 to 4025 | 1 to 4025 | exact | RefSeq, AAA | 4025/4025 (100 %) | 1 diff (100.0 %id) | ||
| AL701387 | human skeletal muscle | .a | 8 to 537 | 1 to 529 | tiling clone, | 529/529 (100 %) | 7 diff (98.7 %id) | ||
| AL702056 | human skeletal muscle | .a | 12 to 604 | 1 to 592 | 592/592 (100 %) | 2 diff (99.7 %id) | |||
| DA489399 | brain | .a | 13 to 573 | 2 to 562 | tiling clone, capped | 561/561 (100 %) | 0 diff (100 %id) | ||
| CN481050 | eye | .a | 13 to 606 | 1 to 594 | 594/594 (100 %) | 1 diff (99.9 %id) | |||
| DA428741 | colon | .a | 14 to 507 | 2 to 495 | capped | 494/494 (100 %) | 0 diff (100 %id) | ||
| DA437577 | tongue, tumor tissue | .a | 22 to 593 | 2 to 574 | capped | 573/573 (100 %) | 1 diff (99.9 %id) | ||
| CN301568 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .a | 26 to 792 | 1 to 767 | tiling clone, | 767/767 (100 %) | 5 diff (99.4 %id) | ||
| DN996900 | breast cancer, Mammary gland (cancer tissue) | .a | 29 to 597 | 1 to 569 | 569/569 (100 %) | 5 diff (99.2 %id) | |||
| DA458696 | tongue, tumor tissue | .a | 42 to 521 | 2 to 481 | capped | 480/480 (100 %) | 3 diff (99.4 %id) | ||
| BQ423781 | melanotic melanoma, skin | .a | 43 to 886 | 1 to 846 | tiling clone, | 846/901 (93 %) | 11 diff (98.8 %id) | ||
| AF151782 | .a | 155 to 4008 | 1 to 3882 | F2R S5R S6A T7R V8R ... | 3882/3882 (100 %) | 16 diff (99.6 %id) | |||
| DA244976 | brain | .b | 1 to 585 | 2 to 586 | tiling clone, capped | 585/585 (100 %) | 0 diff (100 %id) | ||
| CV575471 | cornea, eye | .b | 20 to 639 | 1 to 620 | 620/620 (100 %) | 0 diff (100 %id) | |||
| AJ132637 | .b | 21 to 3875 | 1 to 3858 | exact | tiling clone, AAA | 3858/3858 (100 %) | 10 diff (99.8 %id) | ||
| DA114252 | cerebellum | .b | 21 to 590 | 2 to 571 | capped | 570/570 (100 %) | 0 diff (100 %id) | ||
| NM_014263.2 | .b | 22 to 3875 | 1 to 3854 | exact | RefSeq, AAA | 3854/3854 (100 %) | 0 diff (100 %id) | ||
| AL708518 | human skeletal muscle | .b | 25 to 682 | 1 to 658 | 658/658 (100 %) | 0 diff (100 %id) | |||
| DB227821 | trachea | .b | 26 to 588 | 2 to 564 | capped | 563/563 (100 %) | 0 diff (100 %id) | ||
| DA056483 | cerebellum | .b | 27 to 626 | 2 to 601 | capped | 600/600 (100 %) | 0 diff (100 %id) | ||
| BU188199 | melanotic melanoma, skin | .b | 29 to 848 | 1 to 820 | 820/827 (99 %) | 4 diff (99.6 %id) | |||
| BX509109 | .b | 30 to 744 | 1 to 714 | 714/715 (99 %) | 2 diff (99.8 %id) | ||||
| DA947131 | Spleen | .b | 30 to 584 | 2 to 556 | capped | 555/555 (100 %) | 0 diff (100 %id) | ||
| DA008969 | adrenal gland | .b | 31 to 588 | 2 to 559 | capped | 558/558 (100 %) | 0 diff (100 %id) | ||
| DA069553 | cerebellum | .b | 31 to 601 | 2 to 572 | capped | 571/571 (100 %) | 0 diff (100 %id) | ||
| DA114682 | cerebellum | .b | 31 to 588 | 2 to 559 | capped | 558/558 (100 %) | 0 diff (100 %id) | ||
| DA302236 | hippocampus | .b | 31 to 596 | 2 to 567 | capped | 566/566 (100 %) | 0 diff (100 %id) | ||
| DA409605 | thalamus | .b | 31 to 592 | 2 to 563 | capped | 562/562 (100 %) | 0 diff (100 %id) | ||
| DA441518 | tongue, tumor tissue | .b | 31 to 611 | 2 to 582 | capped | 581/581 (100 %) | 0 diff (100 %id) | ||
| AL709289 | human skeletal muscle | .b | 31 to 632 | 1 to 602 | 602/602 (100 %) | 0 diff (100 %id) | |||
| DA522647 | brain | .b | 31 to 594 | 2 to 565 | capped | 564/564 (100 %) | 0 diff (100 %id) | ||
| DA552912 | .b | 31 to 588 | 2 to 559 | capped | 558/558 (100 %) | 0 diff (100 %id) | |||
| BU147084 | dorsal root ganglia | .b | 31 to 860 | 1 to 838 | 838/884 (94 %) | 16 diff (98.2 %id) | |||
| DA721643 | .b | 31 to 590 | 2 to 561 | capped | 560/560 (100 %) | 0 diff (100 %id) | |||
| DA756949 | .b | 31 to 607 | 2 to 578 | capped | 577/577 (100 %) | 0 diff (100 %id) | |||
| DA875701 | Prostate | .b | 31 to 593 | 2 to 564 | capped | 563/563 (100 %) | 0 diff (100 %id) | ||
| DA907027 | .b | 31 to 593 | 2 to 564 | capped | 563/563 (100 %) | 0 diff (100 %id) | |||
| DB055022 | testis | .b | 31 to 608 | 2 to 579 | capped | 578/578 (100 %) | 0 diff (100 %id) | ||
| DB092450 | testis | .b | 31 to 583 | 2 to 554 | capped | 553/553 (100 %) | 0 diff (100 %id) | ||
| DB097196 | testis | .b | 31 to 615 | 2 to 586 | capped | 585/585 (100 %) | 0 diff (100 %id) | ||
| DB149467 | thymus | .b | 31 to 588 | 2 to 559 | capped | 558/558 (100 %) | 0 diff (100 %id) | ||
| DA480233 | .b | 33 to 588 | 2 to 557 | capped | 556/556 (100 %) | 0 diff (100 %id) | |||
| DA507158 | brain | .b | 33 to 596 | 2 to 565 | capped | 564/564 (100 %) | 0 diff (100 %id) | ||
| DB225642 | trachea | .b | 33 to 588 | 2 to 557 | capped | 556/556 (100 %) | 0 diff (100 %id) | ||
| BM787580 | stomach | .b | 34 to 711 | 1 to 678 | 678/678 (100 %) | 0 diff (100 %id) | |||
| DA297364 | hippocampus | .b | 35 to 615 | 2 to 582 | capped | 581/581 (100 %) | 0 diff (100 %id) | ||
| DA557035 | .b | 35 to 606 | 2 to 573 | capped | 572/572 (100 %) | 0 diff (100 %id) | |||
| DA597721 | .b | 35 to 584 | 2 to 551 | capped | 550/550 (100 %) | 0 diff (100 %id) | |||
| DA625693 | Kidney | .b | 35 to 592 | 2 to 559 | capped | 558/558 (100 %) | 0 diff (100 %id) | ||
| DA757673 | .b | 35 to 604 | 2 to 571 | capped | 570/570 (100 %) | 0 diff (100 %id) | |||
| DA911628 | .b | 35 to 584 | 2 to 551 | capped | 550/550 (100 %) | 0 diff (100 %id) | |||
| DB259382 | uterus | .b | 35 to 614 | 2 to 581 | capped | 580/580 (100 %) | 0 diff (100 %id) | ||
| DA573928 | .b | 37 to 604 | 2 to 569 | capped | 568/568 (100 %) | 0 diff (100 %id) | |||
| CX757369 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .b | 37 to 807 | 1 to 771 | Submitted on the opposite strand | 771/774 (99 %) | 2 diff (99.8 %id) | ||
| DA721592 | .b | 38 to 602 | 2 to 566 | capped | 565/565 (100 %) | 0 diff (100 %id) | |||
| CX867140 | embryonic stem | .b | 39 to 850 | 1 to 812 | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 812/812 (100 %) | 0 diff (100 %id) | ||
| DA952491 | Spleen | .b | 40 to 611 | 2 to 573 | capped | 572/572 (100 %) | 0 diff (100 %id) | ||
| DA234281 | brain | .b | 41 to 613 | 2 to 574 | capped | 573/573 (100 %) | 0 diff (100 %id) | ||
| DA529641 | brain | .b | 41 to 648 | 2 to 609 | capped | 608/610 (99 %) | 1 diff (99.9 %id) | ||
| DA748160 | .b | 41 to 599 | 2 to 560 | capped | 559/559 (100 %) | 0 diff (100 %id) | |||
| DA814903 | .b | 41 to 620 | 2 to 581 | capped | 580/580 (100 %) | 0 diff (100 %id) | |||
| DA816555 | .b | 41 to 604 | 2 to 565 | capped | 564/564 (100 %) | 0 diff (100 %id) | |||
| DA915012 | .b | 41 to 594 | 2 to 555 | capped | 554/554 (100 %) | 0 diff (100 %id) | |||
| DB132170 | thymus | .b | 41 to 610 | 2 to 571 | capped | 570/570 (100 %) | 0 diff (100 %id) | ||
| DB238416 | trachea | .b | 41 to 643 | 2 to 604 | capped | 603/603 (100 %) | 0 diff (100 %id) | ||
| DA165251 | amygdala | .b | 42 to 611 | 2 to 571 | capped | 570/570 (100 %) | 0 diff (100 %id) | ||
| DB083968 | testis | .b | 42 to 594 | 2 to 554 | capped | 553/553 (100 %) | 0 diff (100 %id) | ||
| DA103852 | cerebellum | .b | 43 to 598 | 2 to 557 | capped | 556/556 (100 %) | 0 diff (100 %id) | ||
| DA114274 | cerebellum | .b | 43 to 605 | 2 to 564 | capped | 563/563 (100 %) | 0 diff (100 %id) | ||
| DA175861 | amygdala | .b | 43 to 608 | 2 to 567 | capped | 566/566 (100 %) | 0 diff (100 %id) | ||
| DA196359 | amygdala | .b | 43 to 613 | 2 to 572 | capped | 571/571 (100 %) | 0 diff (100 %id) | ||
| DA351727 | substantia nigra | .b | 43 to 598 | 2 to 557 | capped | 556/556 (100 %) | 0 diff (100 %id) | ||
| DA394014 | thalamus | .b | 43 to 633 | 2 to 592 | capped | 591/591 (100 %) | 0 diff (100 %id) | ||
| DA396812 | thalamus | .b | 43 to 641 | 2 to 600 | capped | 599/599 (100 %) | 0 diff (100 %id) | ||
| DA415926 | thalamus | .b | 43 to 605 | 2 to 564 | capped | 563/563 (100 %) | 0 diff (100 %id) | ||
| DA444077 | tongue, tumor tissue | .b | 43 to 615 | 2 to 574 | capped | 573/573 (100 %) | 0 diff (100 %id) | ||
| DA656424 | .b | 43 to 613 | 2 to 572 | capped | 571/571 (100 %) | 0 diff (100 %id) | |||
| DA726195 | .b | 43 to 601 | 2 to 560 | capped | 559/559 (100 %) | 0 diff (100 %id) | |||
| DA762945 | tongue | .b | 43 to 613 | 2 to 572 | capped | 571/571 (100 %) | 0 diff (100 %id) | ||
| DA800040 | brain | .b | 43 to 598 | 2 to 557 | capped | 556/556 (100 %) | 0 diff (100 %id) | ||
| DA885889 | .b | 43 to 599 | 2 to 558 | capped | 557/557 (100 %) | 0 diff (100 %id) | |||
| DA905892 | .b | 43 to 614 | 2 to 573 | capped | 572/572 (100 %) | 0 diff (100 %id) | |||
| DB039594 | testis | .b | 43 to 605 | 2 to 564 | capped | 563/563 (100 %) | 0 diff (100 %id) | ||
| DB086286 | testis | .b | 43 to 596 | 2 to 555 | capped | 554/554 (100 %) | 0 diff (100 %id) | ||
| DB105512 | thymus | .b | 43 to 618 | 2 to 577 | capped | 576/576 (100 %) | 0 diff (100 %id) | ||
| DB110455 | thymus | .b | 43 to 618 | 2 to 577 | capped | 576/576 (100 %) | 0 diff (100 %id) | ||
| DB141045 | thymus | .b | 43 to 599 | 2 to 558 | capped | 557/557 (100 %) | 0 diff (100 %id) | ||
| DB154131 | thymus | .b | 43 to 635 | 2 to 594 | capped | 593/593 (100 %) | 0 diff (100 %id) | ||
| DB199138 | trachea | .b | 43 to 599 | 2 to 558 | capped | 557/557 (100 %) | 0 diff (100 %id) | ||
| DB224179 | trachea | .b | 43 to 612 | 2 to 571 | capped | 570/570 (100 %) | 0 diff (100 %id) | ||
| DB256393 | uterus | .b | 43 to 612 | 2 to 571 | capped | 570/570 (100 %) | 0 diff (100 %id) | ||
| DB275788 | uterus | .b | 43 to 607 | 2 to 566 | capped | 565/565 (100 %) | 0 diff (100 %id) | ||
| DB292303 | uterus | .b | 43 to 615 | 2 to 574 | capped | 573/573 (100 %) | 0 diff (100 %id) | ||
| DA274374 | corpus callosum | .b | 44 to 609 | 2 to 567 | capped | 566/566 (100 %) | 0 diff (100 %id) | ||
| DA954119 | Spleen | .b | 45 to 617 | 2 to 574 | capped | 573/573 (100 %) | 0 diff (100 %id) | ||
| DA207509 | brain | .b | 46 to 625 | 2 to 581 | capped | 580/580 (100 %) | 0 diff (100 %id) | ||
| DA300849 | hippocampus | .b | 46 to 616 | 2 to 572 | capped | 571/571 (100 %) | 0 diff (100 %id) | ||
| DA440196 | tongue, tumor tissue | .b | 46 to 617 | 2 to 573 | capped | 572/572 (100 %) | 0 diff (100 %id) | ||
| DA506968 | brain | .b | 46 to 602 | 2 to 558 | capped | 557/557 (100 %) | 0 diff (100 %id) | ||
| DA711941 | .b | 46 to 607 | 2 to 563 | capped | 562/562 (100 %) | 0 diff (100 %id) | |||
| DA748029 | .b | 46 to 607 | 2 to 563 | capped | 562/562 (100 %) | 0 diff (100 %id) | |||
| DA497361 | brain | .b | 47 to 613 | 2 to 568 | capped | 567/567 (100 %) | 0 diff (100 %id) | ||
| BM468415 | melanotic melanoma, skin | .b | 47 to 988 | 1 to 944 | 944/987 (95 %) | 11 diff (98.9 %id) | |||
| BI830135 | brain, medulla | .b | 49 to 778 | 1 to 730 | 730/730 (100 %) | 0 diff (100 %id) | |||
| DA959681 | Spleen | .b | 50 to 602 | 2 to 554 | capped | 553/553 (100 %) | 0 diff (100 %id) | ||
| BC023507 | Placenta, choriocarcinoma | .b | 52 to 3257 | 1 to 3206 | exact | available from MGC, AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 3206/3206 (100 %) | 1 diff (100.0 %id) |
| CN301561 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .b | 52 to 728 | 1 to 677 | 677/677 (100 %) | 0 diff (100 %id) | |||
| BX426567 | T cells (Jurkat cell line) | .b | 52 to 1062 | 1 to 1002 | 1002/1003 (99 %) | 15 diff (98.6 %id) | |||
| BP872267 | embryonal kidney | .b | 52 to 629 | 1 to 578 | 578/578 (100 %) | 0 diff (100 %id) | |||
| DA439108 | tongue, tumor tissue | .b | 55 to 607 | 2 to 554 | capped | 553/553 (100 %) | 0 diff (100 %id) | ||
| DA448937 | tongue, tumor tissue | .b | 55 to 605 | 2 to 552 | capped | 551/551 (100 %) | 0 diff (100 %id) | ||
| BM556685 | duodenal adenocarcinoma, cell line, small intestine | .b | 57 to 895 | 1 to 848 | 848/997 (85 %) | 25 diff (97.5 %id) | |||
| BQ070362 | brain, neuroblastoma, cell line | .b | 57 to 1062 | 1 to 1017 | 1017/1018 (99 %) | 35 diff (96.6 %id) | |||
| BU155006 | melanotic melanoma, skin | .b | 58 to 873 | 1 to 830 | 830/896 (92 %) | 17 diff (98.2 %id) | |||
| DA475260 | .b | 60 to 620 | 2 to 562 | capped | 561/561 (100 %) | 0 diff (100 %id) | |||
| DB016526 | esophageal, tumor tissue | .b | 61 to 627 | 2 to 568 | capped | 567/567 (100 %) | 0 diff (100 %id) | ||
| DB249650 | uterus | .b | 61 to 614 | 2 to 555 | capped | 554/554 (100 %) | 0 diff (100 %id) | ||
| BG120678 | adenocarcinoma, cell line, Liver | .b | 62 to 886 | 1 to 817 | 817/885 (92 %) | 34 diff (96.2 %id) | |||
| AK291292 | tongue | .b | 65 to 2586 | 1 to 2522 | T25I | 2522/2522 (100 %) | 2 diff (100.0 %id) | ||
| DA012218 | adrenal gland | .b | 66 to 633 | 2 to 569 | capped | 568/568 (100 %) | 0 diff (100 %id) | ||
| AK314372 | .b | 66 to 2354 | 1 to 2289 | exact | 2289/2289 (100 %) | 0 diff (100 %id) | |||
| DA239478 | brain | .b | 66 to 656 | 2 to 592 | capped | 591/591 (100 %) | 0 diff (100 %id) | ||
| DA451959 | tongue, tumor tissue | .b | 66 to 629 | 2 to 565 | capped | 564/564 (100 %) | 0 diff (100 %id) | ||
| DA453520 | tongue, tumor tissue | .b | 66 to 635 | 2 to 571 | capped | 570/570 (100 %) | 0 diff (100 %id) | ||
| DA458585 | tongue, tumor tissue | .b | 66 to 642 | 2 to 578 | capped | 577/577 (100 %) | 0 diff (100 %id) | ||
| DA458903 | tongue, tumor tissue | .b | 66 to 630 | 2 to 566 | capped | 565/565 (100 %) | 0 diff (100 %id) | ||
| DA479595 | .b | 66 to 617 | 2 to 553 | capped | 552/552 (100 %) | 0 diff (100 %id) | |||
| DA549900 | .b | 66 to 642 | 2 to 578 | capped | 577/577 (100 %) | 0 diff (100 %id) | |||
| DA573354 | .b | 66 to 894 | 2 to 826 | capped | 825/849 (97 %) | 13 diff (98.5 %id) | |||
| DA578474 | .b | 66 to 631 | 2 to 567 | capped | 566/566 (100 %) | 0 diff (100 %id) | |||
| DA642820 | Liver | .b | 66 to 631 | 2 to 567 | capped | 566/566 (100 %) | 0 diff (100 %id) | ||
| DA679590 | .b | 66 to 629 | 2 to 565 | capped | 564/564 (100 %) | 0 diff (100 %id) | |||
| DA706703 | .b | 66 to 641 | 2 to 577 | capped | 576/576 (100 %) | 0 diff (100 %id) | |||
| DA725734 | .b | 66 to 626 | 2 to 562 | capped | 561/561 (100 %) | 0 diff (100 %id) | |||
| DA726528 | .b | 66 to 620 | 2 to 556 | capped | 555/555 (100 %) | 0 diff (100 %id) | |||
| DA925732 | small intestine | .b | 66 to 651 | 2 to 587 | capped | 586/586 (100 %) | 0 diff (100 %id) | ||
| DB021354 | testis | .b | 66 to 635 | 2 to 571 | capped | 570/570 (100 %) | 0 diff (100 %id) | ||
| DB089918 | testis | .b | 66 to 628 | 2 to 564 | capped | 563/563 (100 %) | 0 diff (100 %id) | ||
| DB159536 | thymus | .b | 66 to 658 | 2 to 594 | capped | 593/593 (100 %) | 0 diff (100 %id) | ||
| CN301536 | embryonic stem cells, cell lines H1, H7, andH9 | .b | 67 to 698 | 1 to 632 | 632/632 (100 %) | 0 diff (100 %id) | |||
| DA720357 | .b | 67 to 640 | 2 to 575 | capped | 574/574 (100 %) | 0 diff (100 %id) | |||
| DB100083 | testis | .b | 67 to 658 | 2 to 593 | capped | 592/592 (100 %) | 0 diff (100 %id) | ||
| DB165727 | thymus | .b | 67 to 639 | 2 to 574 | capped | 573/573 (100 %) | 0 diff (100 %id) | ||
| AY358484 | .b | 68 to 2592 | 1 to 2525 | exact | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 2525/2525 (100 %) | 1 diff (100.0 %id) | |
| BX472489 | .b | 69 to 645 | 1 to 577 | 577/577 (100 %) | 0 diff (100 %id) | ||||
| DA654751 | .b | 71 to 635 | 2 to 566 | capped | 565/565 (100 %) | 0 diff (100 %id) | |||
| DB259898 | uterus | .b | 72 to 648 | 2 to 578 | capped | 577/577 (100 %) | 0 diff (100 %id) | ||
| DA738427 | .b | 73 to 894 | 2 to 820 | capped | 819/856 (95 %) | 14 diff (98.4 %id) | |||
| BQ425509 | leiomyosarcoma, uterus | .b | 74 to 946 | 1 to 878 | 878/878 (100 %) | 12 diff (98.7 %id) | |||
| BX406565 | fetal liver, Liver | .b | 77 to 371 | 1 to 295 | 295/295 (100 %) | 0 diff (100 %id) | |||
| BQ224171 | embryonal carcinoma, cell line, testis | .b | 80 to 915 | 1 to 842 | 840/842 (99 %) | 10 diff (98.9 %id) | |||
| DB123820 | thymus | .b | 82 to 672 | 2 to 592 | capped | 591/591 (100 %) | 0 diff (100 %id) | ||
| BG686160 | B-cells, primary B-cells from tonsils (cell line) | .b | 85 to 759 | 1 to 675 | 675/678 (99 %) | 2 diff (99.8 %id) | |||
| BX425858 | neuroblastoma | .b | 89 to 1153 | 1 to 1060 | 1060/1060 (100 %) | 7 diff (99.4 %id) | |||
| BM471360 | melanotic melanoma, skin | .b | 112 to 1098 | 1 to 990 | 988/990 (99 %) | 15 diff (98.5 %id) | |||
| DB089229 | testis | .b | 114 to 675 | 2 to 563 | capped | 562/562 (100 %) | 0 diff (100 %id) | ||
| BQ437066 | melanotic melanoma, skin | .b | 115 to 974 | 1 to 868 | 866/871 (99 %) | 13 diff (98.6 %id) | |||
| CN301558 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .b | 117 to 740 | 1 to 624 | 624/624 (100 %) | 0 diff (100 %id) | |||
| CN301570 | embryonic stem cells, cell lines H1, H7, andH9 | .b | 117 to 829 | 1 to 713 | 713/713 (100 %) | 0 diff (100 %id) | |||
| DR761953 | embryonic stem | .b | 207 to 1029 | 1 to 823 | 823/823 (100 %) | 0 diff (100 %id) | |||
| CB215705 | normal endometrium, late proliferativephase, cycle day 13, uterus | .b | 280 to 891 | 1 to 612 | 612/612 (100 %) | 0 diff (100 %id) | |||
| BU169709 | embryonal carcinoma, cell line, testis | .b | 294 to 1166 | 1 to 881 | 881/883 (99 %) | 14 diff (98.5 %id) | |||
| DB101677 | thymus | .b | 369 to 941 | 2 to 574 | capped | 573/573 (100 %) | 0 diff (100 %id) | ||
| BF793595 | adrenal cortex carcinoma, cell line, adrenal gland | .b | 399 to 1157 | 1 to 752 | 752/931 (80 %) | 16 diff (98.3 %id) | |||
| CV573365 | cornea, eye | .b | 455 to 1066 | 1 to 612 | 612/612 (100 %) | 0 diff (100 %id) | |||
| AL559492 | T cells from T cell leukemia | .b | 534 to 1386 | 1 to 853 | 853/853 (100 %) | 0 diff (100 %id) | |||
| DB245697 | uterus, tumor tissue | .b | 550 to 1113 | 2 to 565 | capped | 564/564 (100 %) | 0 diff (100 %id) | ||
| DA666879 | .b | 640 to 1201 | 2 to 563 | capped | 562/562 (100 %) | 0 diff (100 %id) | |||
| DA484910 | brain | .b | 655 to 1221 | 2 to 568 | capped | 567/567 (100 %) | 0 diff (100 %id) | ||
| AF070656 | .b | 678 to 2596 | 1 to 1917 | 1917/1922 (99 %) | 4 diff (99.8 %id) | ||||
| AL701219 | human skeletal muscle | .b | 736 to 1349 | 1 to 615 | 615/615 (100 %) | 1 diff (99.9 %id) | |||
| DA546162 | .b | 827 to 1384 | 2 to 559 | capped | 558/558 (100 %) | 0 diff (100 %id) | |||
| DA084438 | cerebellum | .b | 835 to 1391 | 2 to 558 | capped | 557/557 (100 %) | 0 diff (100 %id) | ||
| DA577698 | .b | 843 to 1405 | 2 to 564 | capped | 563/563 (100 %) | 0 diff (100 %id) | |||
| DA023843 | .b | 880 to 1452 | 2 to 574 | capped | 573/573 (100 %) | 0 diff (100 %id) | |||
| DB261193 | uterus | .b | 892 to 1453 | 2 to 563 | capped | 562/562 (100 %) | 0 diff (100 %id) | ||
| DA021038 | .b | 897 to 1479 | 2 to 584 | capped | 583/583 (100 %) | 0 diff (100 %id) | |||
| BI856907 | breast, mammary adenocarcinoma, cell line | .b | 911 to 1541 | 1 to 631 | 631/631 (100 %) | 1 diff (99.9 %id) | |||
| BG254700 | adenocarcinoma, cell line, Prostate | .b | 917 to 1708 | 1 to 792 | 792/874 (90 %) | 23 diff (97.4 %id) | |||
| DA751602 | .b | 1061 to 1614 | 9 to 562 | capped | 554/561 (98 %) | 6 diff (99.0 %id) | |||
| DA888685 | .b | 1079 to 1643 | 2 to 566 | capped | 565/565 (100 %) | 0 diff (100 %id) | |||
| DB180527 | kidney, tumor tissue | .b | 1093 to 1647 | 2 to 556 | capped | 555/555 (100 %) | 0 diff (100 %id) | ||
| BQ717013 | sympathetic trunk | .b | 1141 to 1977 | 1 to 845 | 843/882 (95 %) | 15 diff (98.3 %id) | |||
| DA690321 | .b | 1157 to 1739 | 2 to 584 | capped | 583/583 (100 %) | 0 diff (100 %id) | |||
| AK001259 | .b | 1232 to 3257 | 1 to 2024 | available from FLJ, | 2024/2024 (100 %) | 5 diff (99.8 %id) | |||
| DA273943 | corpus callosum | .b | 1232 to 1797 | 2 to 567 | capped | 566/566 (100 %) | 0 diff (100 %id) | ||
| DB111621 | thymus | .b | 1263 to 1826 | 2 to 565 | capped | 564/564 (100 %) | 0 diff (100 %id) | ||
| BM756343 | Ascites, stomach | .b | 1304 to 1989 | 1 to 686 | 686/686 (100 %) | 0 diff (100 %id) | |||
| BM768047 | Ascites, stomach | .b | 1304 to 1974 | 1 to 671 | 671/671 (100 %) | 0 diff (100 %id) | |||
| BM770338 | Ascites, stomach | .b | 1304 to 1903 | 1 to 600 | 600/600 (100 %) | 0 diff (100 %id) | |||
| DA600258 | .b | 1343 to 1898 | 2 to 557 | capped | 556/556 (100 %) | 0 diff (100 %id) | |||
| CB161024 | Liver | .b | 1447 to 2081 | 1 to 635 | 635/635 (100 %) | 0 diff (100 %id) | |||
| BQ940003 | leiomyosarcoma, uterus | .b | 1481 to 2343 | 1 to 866 | 866/867 (99 %) | 4 diff (99.6 %id) | |||
| CX784086 | human embryonic stem cells | .b | 1552 to 2264 | 1 to 713 | 713/713 (100 %) | 0 diff (100 %id) | |||
| BX426566 | T cells (Jurkat cell line) | .b | 1606 to 2564 | 957 to 1 | 957/1045 (91 %) | 15 diff (98.6 %id) | |||
| TI_149303055 | .b | 1646 to 2592 | 1013 to 84 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 930/976 (95 %) | 26 diff (97.4 %id) | ||
| TI_149302702 | .b | 1709 to 2592 | 933 to 58 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 876/970 (90 %) | 16 diff (98.4 %id) | ||
| CR987210 | T-Lymphocytes | .b | 1713 to 2644 | 1 to 926 | 926/949 (97 %) | 10 diff (99.0 %id) | |||
| CB119538 | Liver | .b | 1719 to 2305 | 1 to 587 | 587/587 (100 %) | 0 diff (100 %id) | |||
| CN301537 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .b | 1738 to 2488 | 1 to 751 | 751/751 (100 %) | 1 diff (99.9 %id) | |||
| BM761552 | myeloma | .b | 1738 to 2310 | 1 to 573 | 573/573 (100 %) | 0 diff (100 %id) | |||
| TI_154108360 | .b | 1770 to 2592 | 903 to 83 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 821/945 (86 %) | 6 diff (99.4 %id) | ||
| AA452392 | .b | 1776 to 2241 | 1 to 466 | fully sequenced, | 466/466 (100 %) | 0 diff (100 %id) | |||
| CA447519 | Chondrosarcoma, Left Pelvis | .b | 1814 to 2592 | 796 to 19 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 778/778 (100 %) | 4 diff (99.5 %id) | |
| BM981137 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .b | 1815 to 2592 | 796 to 19 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 778/778 (100 %) | 1 diff (99.9 %id) | |
| BM980852 | lung, Primary Lung Cystic Fibrosis EpithelialCells | .b | 1942 to 2592 | 667 to 19 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 649/649 (100 %) | 1 diff (99.9 %id) | |
| AW138746 | .b | 2012 to 2597 | 603 to 18 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 586/586 (100 %) | 0 diff (100 %id) | ||
| CX867059 | embryonic stem | .b | 2102 to 2774 | 699 to 27 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 673/673 (100 %) | 2 diff (99.8 %id) | |
| AA452161 | .b | 2180 to 2596 | 417 to 1 | fully sequenced, | 417/417 (100 %) | 1 diff (99.8 %id) | |||
| AW955309 | .b | 2493 to 3203 | 1 to 711 | 711/716 (99 %) | 14 diff (98.1 %id) | ||||
| CN301534 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .b | 2496 to 3164 | 1 to 669 | 669/669 (100 %) | 1 diff (99.9 %id) | |||
| AU138715 | placenta | .b | 2633 to 3286 | 2 to 658 | capped | 657/657 (100 %) | 4 diff (99.4 %id) | ||
| BM995282 | Chondrosarcoma, Left Pubic Bone | .b | 2661 to 3257 | 614 to 19 | AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 596/599 (99 %) | 2 diff (99.7 %id) | |
| AI904692 | breast | .b | 2731 to 2888 | 1 to 158 | 158/159 (99 %) | 1 diff (99.4 %id) | |||
| EH323327 | .b | 2751 to 2829 | 1 to 78 | 78/78 (100 %) | 1 diff (98.8 %id) | ||||
| AI982808 | adenocarcinoma, Pancreas | .b | 2771 to 3257 | 489 to 1 | 489/489 (100 %) | 4 diff (99.2 %id) | |||
| CA310172 | Alveolar Macrophage, lung | .b | 2775 to 3586 | 829 to 19 | tiling clone, AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 811/811 (100 %) | 1 diff (99.9 %id) | |
| CN301553 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .b | 2815 to 3563 | 1 to 750 | 750/750 (100 %) | 6 diff (99.2 %id) | |||
| CD638804 | pooled | .b | 2826 to 3425 | 1 to 602 | 602/602 (100 %) | 6 diff (99.1 %id) | |||
| BG497396 | lung, mucoepidermoid carcinoma | .b | 2838 to 3454 | 1 to 620 | 620/925 (67 %) | 6 diff (99.4 %id) | |||
| AW963623 | .b | 2848 to 3585 | 1 to 739 | 739/742 (99 %) | 9 diff (98.8 %id) | ||||
| BQ019457 | Chondrosarcoma, Left Pubic Bone | .b | 2848 to 3480 | 649 to 17 | AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 633/633 (100 %) | 5 diff (99.3 %id) | |
| BQ019826 | Chondrosarcoma, Left Pubic Bone | .b | 2911 to 3480 | 586 to 17 | AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 570/570 (100 %) | 0 diff (100 %id) | |
| CN301542 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .b | 2950 to 3617 | 1 to 668 | 668/668 (100 %) | 0 diff (100 %id) | |||
| BM996317 | lung, Metastatic Chondrosarcoma | .b | 2955 to 3592 | 657 to 19 | AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 639/639 (100 %) | 1 diff (99.9 %id) | |
| TI_154101543 | .b | 3047 to 3875 | 903 to 85 | AAA | 819/819 (100 %) | 30 diff (96.4 %id) | |||
| TI_149271501 | .b | 3091 to 3875 | 862 to 86 | AAA | 777/944 (82 %) | 26 diff (97.3 %id) | |||
| BX485956 | .b | 3102 to 3875 | 821 to 47 | AAA | Submitted on the opposite strand | 775/775 (100 %) | 1 diff (99.9 %id) | ||
| BQ230570 | melanotic melanoma, skin | .b | 3124 to 3874 | 1 to 753 | 753/936 (80 %) | 3 diff (99.7 %id) | |||
| BM798155 | Ascites, stomach | .b | 3128 to 3694 | 1 to 567 | 567/567 (100 %) | 0 diff (100 %id) | |||
| CA306353 | Alveolar Macrophage, lung | .b | 3158 to 3875 | 733 to 16 | AAA | 718/718 (100 %) | 0 diff (100 %id) | ||
| TI_154130307 | .b | 3167 to 3875 | 816 to 107 | AAA | 710/964 (73 %) | 7 diff (99.3 %id) | |||
| EL951084 | eyeball | .b | 3186 to 3681 | 1 to 495 | 495/495 (100 %) | 4 diff (99.2 %id) | |||
| CA426140 | Bone, Subchondral Bone | .b | 3186 to 3875 | 710 to 19 | AAA | 692/692 (100 %) | 2 diff (99.8 %id) | ||
| BF878409 | lung_tumor | .b | 3190 to 3700 | 539 to 27 | Submitted on the opposite strand | 513/539 (95 %) | 0 diff (100 %id) | ||
| TI_149306001 | .b | 3200 to 3872 | 761 to 87 | AAA | 675/903 (74 %) | 3 diff (99.7 %id) | |||
| BU686181 | lung, Primary Lung Epithelial Cells | .b | 3200 to 3872 | 693 to 19 | AAA | 675/688 (98 %) | 3 diff (99.6 %id) | ||
| AA989107 | carcinoid, lung | .b | 3282 to 3587 | 307 to 2 | 306/307 (99 %) | 0 diff (100 %id) | |||
| DB378664 | placenta | .b | 3289 to 3871 | 583 to 6 | 578/586 (98 %) | 0 diff (100 %id) | |||
| C06118 | .b | 3319 to 3877 | 565 to 6 | 560/565 (99 %) | 0 diff (100 %id) | ||||
| AA513735 | breast | .b | 3381 to 3875 | 495 to 1 | 495/495 (100 %) | 0 diff (100 %id) | |||
| CF130197 | Chondrosarcoma Lung Metastasis cell lines, lung | .b | 3383 to 3875 | 1 to 493 | AAA | 493/493 (100 %) | 0 diff (100 %id) | ||
| TI_154192138 | .b | 3383 to 3875 | 48 to 540 | AAA | 493/493 (100 %) | 0 diff (100 %id) | |||
| AI301983 | carcinoid, lung | .b | 3402 to 3587 | 187 to 2 | 186/187 (99 %) | 0 diff (100 %id) | |||
| BQ027106 | Chondrosarcoma, Left Pubic Bone | .b | 3459 to 4150 | 710 to 19 | tiling clone, AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 692/692 (100 %) | 1 diff (99.9 %id) | |
| AA075084 | .b | 3461 to 3875 | 427 to 12 | AAA | Submitted on the opposite strand | 416/417 (99 %) | 2 diff (99.6 %id) | ||
| TI_149289532 | .b | 3495 to 3871 | 66 to 441 | Submitted on the opposite strand | 376/1080 (34 %) | 5 diff (99.6 %id) | |||
| BU681680 | lung | .b | 3496 to 3871 | 1 to 376 | AAA | Submitted on the opposite strand | 376/384 (97 %) | 7 diff (98.2 %id) | |
| BX406564 | fetal liver, Liver | .b | 3506 to 3831 | 326 to 1 | 326/326 (100 %) | 3 diff (99.1 %id) | |||
| GD146261 | .b | 3744 to 3877 | 1 to 134 | 134/139 (96 %) | 3 diff (97.9 %id) | ||||
| GD152427 | .b | 3747 to 3872 | 1 to 126 | AAA | 126/126 (100 %) | 2 diff (98.5 %id) | |||
| GD152491 | .b | 3747 to 3882 | 1 to 137 | 137/145 (94 %) | 7 diff (95.2 %id) | ||||
| DC363275 | .c | 1 to 543 | 7 to 550 | tiling clone, | 550/550 (100 %) | 3 diff (99.5 %id) | |||
| AK297973 | .c | 10 to 2478 | 1 to 2469 | exact | tiling clone, | 2469/2469 (100 %) | 1 diff (100.0 %id) | ||
| DC352271 | brain | .c | 10 to 662 | 1 to 656 | 656/757 (86 %) | 9 diff (98.9 %id) | |||
| DC357980 | .c | 10 to 558 | 1 to 549 | 549/549 (100 %) | 0 diff (100 %id) | ||||
| DC368264 | .c | 10 to 576 | 1 to 569 | 569/569 (100 %) | 2 diff (99.7 %id) | ||||
| DC364742 | .c | 17 to 566 | 1 to 550 | 550/550 (100 %) | 1 diff (99.9 %id) | ||||
| DC329620 | corpus callosum | .c | 20 to 598 | 1 to 579 | 579/579 (100 %) | 0 diff (100 %id) | |||
| DC371673 | .c | 20 to 566 | 1 to 547 | 547/547 (100 %) | 0 diff (100 %id) | ||||
| DC324055 | brain | .c | 22 to 617 | 1 to 596 | 596/596 (100 %) | 0 diff (100 %id) | |||
| DC342790 | thalamus | .c | 22 to 569 | 1 to 548 | 548/548 (100 %) | 0 diff (100 %id) | |||
| DC383386 | Prostate | .c | 22 to 558 | 1 to 537 | 537/537 (100 %) | 0 diff (100 %id) | |||
| DC379006 | pericardium | .c | 25 to 603 | 1 to 579 | 579/579 (100 %) | 0 diff (100 %id) | |||
| DC299654 | .c | 40 to 603 | 1 to 564 | 564/564 (100 %) | 2 diff (99.7 %id) | ||||
| DC369386 | .c | 40 to 617 | 1 to 578 | 578/578 (100 %) | 0 diff (100 %id) | ||||
| DC332315 | hippocampus | .c | 41 to 577 | 1 to 537 | 537/537 (100 %) | 0 diff (100 %id) | |||
| DC363326 | .c | 44 to 578 | 1 to 537 | 537/537 (100 %) | 5 diff (99.1 %id) | ||||
| DC414899 | trachea | .c | 44 to 566 | 1 to 523 | 523/523 (100 %) | 2 diff (99.7 %id) | |||
| DC422221 | uterus | .c | 44 to 593 | 1 to 550 | 550/550 (100 %) | 3 diff (99.5 %id) | |||
| DC300087 | .c | 45 to 613 | 1 to 569 | 569/569 (100 %) | 1 diff (99.9 %id) | ||||
| DC385275 | .c | 45 to 608 | 1 to 564 | 564/564 (100 %) | 2 diff (99.7 %id) | ||||
| DC404322 | testis | .c | 45 to 615 | 1 to 571 | 571/571 (100 %) | 1 diff (99.9 %id) | |||
| DC410254 | thymus | .c | 45 to 621 | 1 to 577 | 577/577 (100 %) | 2 diff (99.7 %id) | |||
| DC422348 | uterus | .c | 45 to 566 | 1 to 523 | 523/523 (100 %) | 1 diff (99.9 %id) | |||
| DA990721 | synovial membrane tissue from rheumatioidarthritis | .c | 46 to 573 | 2 to 532 | capped | 531/531 (100 %) | 5 diff (99.1 %id) | ||
| DA990728 | synovial membrane tissue from rheumatioidarthritis | .c | 46 to 568 | 2 to 527 | capped | 526/526 (100 %) | 5 diff (99.1 %id) | ||
| DC368237 | .c | 47 to 608 | 1 to 562 | 562/562 (100 %) | 0 diff (100 %id) | ||||
| DC351218 | brain | .c | 360 to 943 | 1 to 584 | 584/584 (100 %) | 0 diff (100 %id) | |||
| BM016519 | breast, mammary adenocarcinoma, cell line | .c | 470 to 1209 | 1 to 736 | tiling clone, | 736/740 (99 %) | 5 diff (99.4 %id) | ||
| TI_59394141 | .c | 470 to 1209 | 54 to 789 | 736/740 (99 %) | 5 diff (99.4 %id) | ||||
| DA235488 | brain | .d | 1 to 594 | 2 to 595 | tiling clone, capped | 594/596 (99 %) | 1 diff (99.9 %id) | ||
| DA832317 | placenta | .d | 46 to 766 | 2 to 725 | capped | 724/725 (99 %) | 7 diff (99.1 %id) | ||
| BU156440 | eye, retinoblastoma | .d | 59 to 987 | 1 to 930 | tiling clone, | 930/930 (100 %) | 19 diff (98.0 %id) | ||
| DB132781 | thymus | .d | 68 to 608 | 2 to 543 | capped | 542/542 (100 %) | 5 diff (99.1 %id) | ||
| BE613637 | leiomyosarcoma, uterus | .d | 112 to 866 | 1 to 745 | tiling clone, | 747/964 (77 %) | 19 diff (98.1 %id) | ||
| DN997471 | breast cancer, Mammary gland (cancer tissue) | .d | 173 to 831 | 1 to 659 | tiling clone, | 659/659 (100 %) | 2 diff (99.7 %id) | ||
| DB378446 | placenta | .d | 1680 to 2228 | 545 to 1 | tiling clone, | 545/617 (88 %) | 13 diff (97.9 %id) | ||
| F06870 | brain, total brain | .e | 1 to 300 | 1 to 300 | tiling clone, | 300/300 (100 %) | 0 diff (100 %id) | ||
| F06886 | brain, total brain | .e | 1 to 307 | 1 to 307 | tiling clone, | 307/307 (100 %) | 2 diff (99.4 %id) | ||
| Z39962 | brain, total brain | .e | 1549 to 1857 | 309 to 1 | tiling clone, | 309/316 (97 %) | 0 diff (100 %id) | ||
| F03137 | brain, total brain | .e | 1655 to 1857 | 203 to 1 | 203/203 (100 %) | 0 diff (100 %id) | |||
| CR611030 | T cells (Jurkat cell line) Cot10-normalized | .f | 1 to 1998 | 1 to 1998 | exact | tiling clone, | 1998/1998 (100 %) | 0 diff (100 %id) | |
| TI_151730360 | .g | 1 to 595 | 675 to 83 | A19P L71V Q78K N79P Q80V ... | tiling clone, AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 593/971 (61 %) | 15 diff (98.5 %id) | |
| DB033769 | testis | .h | 1 to 581 | 2 to 582 | exact | tiling clone, capped | 581/581 (100 %) | 0 diff (100 %id) | |
| DA018719 | .i | 1 to 555 | 2 to 556 | exact | tiling clone, capped | 555/555 (100 %) | 1 diff (99.9 %id) | ||
| DA111676 | cerebellum | .j | -11 to 582 | 2 to 595 | capped | 594/594 (100 %) | 2 diff (99.7 %id) | ||
| DA800286 | brain | .j | -11 to 560 | 2 to 573 | capped | 572/574 (99 %) | 1 diff (99.9 %id) | ||
| DW458267 | Liver | .j | -10 to 128 | 18 to 156 | 139/156 (89 %) | 6 diff (96.2 %id) | |||
| AL704773 | human skeletal muscle | .j | -9 to 591 | 1 to 601 | tiling clone, | 601/601 (100 %) | 2 diff (99.7 %id) | ||
| DW423201 | Liver | .j | -9 to 265 | 18 to 292 | 275/292 (94 %) | 6 diff (98.0 %id) | |||
| DA507799 | brain | .j | -9 to 562 | 2 to 573 | capped | 572/572 (100 %) | 1 diff (99.9 %id) | ||
| DB076381 | testis | .j | -9 to 543 | 2 to 554 | capped | 553/553 (100 %) | 0 diff (100 %id) | ||
| AL704757 | human skeletal muscle | .j | 1 to 523 | 8 to 530 | 530/530 (100 %) | 0 diff (100 %id) | |||
| AK022930 | .j | 1 to 3021 | 2 to 3022 | tiling clone, available from FLJ, | 3022/3022 (100 %) | 4 diff (99.9 %id) | |||
| AL706329 | human skeletal muscle | .j | 1 to 604 | 1 to 603 | 603/603 (100 %) | 2 diff (99.7 %id) | |||
| AU128568 | .j | 1 to 522 | 2 to 528 | capped | 527/527 (100 %) | 6 diff (98.9 %id) | |||
| AL712023 | human skeletal muscle | .j | 10 to 687 | 1 to 678 | 678/678 (100 %) | 4 diff (99.5 %id) | |||
| BX504351 | .j | 11 to 737 | 1 to 725 | 725/725 (100 %) | 5 diff (99.4 %id) | ||||
| BQ646939 | hepatocellular carcinoma, cell line, Liver | .j | 21 to 693 | 72 to 750 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 679/754 (90 %) | 11 diff (98.6 %id) | |
| BQ653380 | hepatocellular carcinoma, cell line, Liver | .j | 24 to 638 | 1 to 616 | 616/952 (64 %) | 14 diff (98.6 %id) | |||
| BQ646392 | hepatocellular carcinoma, cell line, Liver | .j | 24 to 697 | 1 to 673 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 673/674 (99 %) | 4 diff (99.5 %id) | |
| DA185061 | amygdala | .j | 38 to 574 | 2 to 538 | capped | 537/537 (100 %) | 1 diff (99.9 %id) | ||
| DB074033 | testis | .j | 38 to 595 | 2 to 559 | capped | 558/558 (100 %) | 0 diff (100 %id) | ||
| CN306080 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .j | 41 to 689 | 1 to 649 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 649/649 (100 %) | 1 diff (99.9 %id) | |
| DA238239 | brain | .j | 43 to 629 | 2 to 589 | capped | 588/588 (100 %) | 1 diff (99.9 %id) | ||
| DW414439 | Liver | .j | 67 to 365 | 18 to 316 | 299/316 (94 %) | 6 diff (98.2 %id) | |||
| DB224585 | trachea | .j | 74 to 605 | 2 to 533 | capped | 532/532 (100 %) | 0 diff (100 %id) | ||
| DW414238 | Liver | .j | 110 to 418 | 10 to 317 | 308/317 (97 %) | 6 diff (98.2 %id) | |||
| DW413877 | Liver | .j | 146 to 446 | 18 to 318 | 301/318 (94 %) | 6 diff (98.2 %id) | |||
| AV735836 | cord Blood | .j | 162 to 693 | 52 to 585 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 534/586 (91 %) | 6 diff (99.0 %id) | |
| W24314 | senescent fibroblast | .j | 185 to 667 | 1 to 494 | fully sequenced, | 494/494 (100 %) | 12 diff (97.6 %id) | ||
| F31162 | pectoral muscle (after mastectomy) | .j | 297 to 656 | 1 to 360 | 360/360 (100 %) | 1 diff (99.8 %id) | |||
| BF911615 | uterus_tumor | .j | 298 to 647 | 1 to 349 | 349/349 (100 %) | 7 diff (98.0 %id) | |||
| N95271 | senescent fibroblast | .j | 316 to 684 | 364 to 1 | fully sequenced, | 364/364 (100 %) | 1 diff (99.8 %id) | ||
| F36583 | pectoral muscle (after mastectomy) | .j | 324 to 690 | 1 to 367 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 367/367 (100 %) | 3 diff (99.2 %id) | |
| DA439065 | tongue, tumor tissue | .j | 465 to 1062 | 2 to 599 | capped | 598/598 (100 %) | 1 diff (99.9 %id) | ||
| BX497238 | Liver | .j | 883 to 1439 | 1 to 557 | 557/557 (100 %) | 0 diff (100 %id) | |||
| DA907487 | .j | 883 to 1441 | 2 to 560 | capped | 559/559 (100 %) | 0 diff (100 %id) | |||
| DB220040 | trachea | .j | 886 to 1445 | 2 to 561 | capped | 560/560 (100 %) | 0 diff (100 %id) | ||
| DA815906 | .j | 890 to 1457 | 2 to 569 | capped | 568/568 (100 %) | 0 diff (100 %id) | |||
| AL710338 | human skeletal muscle | .j | 893 to 1554 | 1 to 662 | S30T | tiling clone, | 662/662 (100 %) | 1 diff (99.9 %id) | |
| DA693554 | .j | 895 to 1465 | 2 to 572 | capped | 571/571 (100 %) | 1 diff (99.9 %id) | |||
| DB129041 | thymus | .j | 917 to 1470 | 2 to 555 | capped | 554/554 (100 %) | 1 diff (99.9 %id) | ||
| DA378003 | thalamus | .j | 918 to 1470 | 2 to 553 | S37Q V38F S39L Q40K N41T ... | capped | 552/552 (100 %) | 3 diff (99.5 %id) | |
| DA686574 | .j | 925 to 1452 | 2 to 530 | capped | 529/529 (100 %) | 1 diff (99.9 %id) | |||
| BC019602 | Eye, retinoblastoma | .j | 937 to 3471 | 1 to 2534 | tiling clone, available from MGC, AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 2534/2534 (100 %) | 3 diff (99.9 %id) | |
| BE618002 | eye, retinoblastoma | .j | 945 to 1523 | 1 to 581 | I76N F77I E78R G79R Y80V ... | available from MGC, | 581/582 (99 %) | 8 diff (98.7 %id) | |
| BE784678 | large cell carcinoma, lung | .j | 1665 to 2233 | 1 to 575 | 575/575 (100 %) | 17 diff (97.1 %id) | |||
| BM793392 | Ascites, stomach | .j | 1891 to 2550 | 1 to 660 | 660/660 (100 %) | 0 diff (100 %id) | |||
| BG027168 | Bone, osteosarcoma, cell line | .j | 2159 to 2850 | 51 to 735 | 685/989 (69 %) | 42 diff (95.8 %id) | |||
| AU150834 | .j | 2465 to 3021 | 554 to 1 | 554/556 (99 %) | 12 diff (97.9 %id) | ||||
| DA384929 | thalamus | .j | 2516 to 3088 | 2 to 572 | tiling clone, capped | 571/571 (100 %) | 2 diff (99.7 %id) | ||
| AA828049 | ovary | .j | 2621 to 3036 | 421 to 6 | 416/421 (98 %) | 0 diff (100 %id) | |||
| FN160271 | breast carcinoma | .j | 2881 to 2966 | 1 to 86 | 86/89 (96 %) | 1 diff (98.9 %id) | |||
| AA809990 | germinal center B cell | .j | 3088 to 3478 | 404 to 14 | AAA | Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) | 391/391 (100 %) | 1 diff (99.8 %id) | |
| N53511 | multiple sclerosis lesions | .j | 3235 to 3526 | 296 to 1 | tiling clone, | 296/413 (71 %) | 4 diff (99.1 %id) | ||
| AA639867 | colon, colon tumor RER+ | .k | 1 to 476 | 485 to -6 | R2L K34E S36L A37Q P38G ... | tiling clone, | 485/485 (100 %) | 4 diff (99.2 %id) | |
| BF000181 | colon, colon tumor, RER+ | .k | 72 to 467 | 404 to 10 | tiling clone, | 395/404 (97 %) | 1 diff (99.8 %id) | ||
| BX457468 | thymus | .l | 1 to 413 | 1 to 413 | W92X R93X | tiling clone, | 413/413 (100 %) | 5 diff (98.8 %id) | |
| AW977603 | .m-u | 1 to 518 | 522 to 1 | tiling clone, | Submitted on the opposite strand | 522/522 (100 %) | 5 diff (99.1 %id) | ||
| AW997043 | breast_normal | .m-u | 6 to 567 | 566 to 5 | tiling clone, | Submitted on the opposite strand | 562/566 (99 %) | 0 diff (100 %id) | |
| AL699480 | human skeletal muscle | .m-u | 108 to 672 | 9 to 573 | 565/565 (100 %) | 1 diff (99.9 %id) | |||
| AA814757 | germinal center B cell | .m-u | 157 to 526 | 376 to 3 | tiling clone, | 374/376 (99 %) | 0 diff (100 %id) | ||
| AA994989 | pooled | .m-u | 184 to 518 | 339 to 1 | 339/339 (100 %) | 2 diff (99.5 %id) | |||
| DA109534 | cerebellum | .m-u | 486 to 1086 | 2 to 602 | exact | tiling clone, to resequence, capped | 601/601 (100 %) | 2 diff (99.7 %id) | |
| DA148735 | amygdala | .m-u | 1923 to 2483 | 2 to 563 | tiling clone, capped | 562/562 (100 %) | 1 diff (99.9 %id) | ||
| BX955564 | .m-u | 2140 to 2553 | 414 to 1 | Submitted on the opposite strand | 414/414 (100 %) | 2 diff (99.6 %id) | |||
| DR759803 | embryonic stem | .m-u | 2199 to 2666 | 1 to 468 | 468/468 (100 %) | 10 diff (97.9 %id) | |||
| AV731531 | hypothalamus | .m-u | 2269 to 2836 | 563 to 1 | tiling clone, | Submitted on the opposite strand | 563/645 (87 %) | 16 diff (97.6 %id) | |
| AW770803 | colon, juvenile granulosa tumor | .m-u | 2398 to 2811 | 413 to 1 | tiling clone, | 413/413 (100 %) | 1 diff (99.8 %id) | ||
| DB299789 | cerebellum | .m-u | 2424 to 2786 | 363 to 1 | to resequence, | 363/363 (100 %) | 0 diff (100 %id) | ||
| DA636298 | Kidney | .n | 1 to 591 | 2 to 592 | tiling clone, capped | 591/591 (100 %) | 0 diff (100 %id) | ||
| DB176249 | kidney, tumor tissue | .n | 1 to 562 | 2 to 563 | capped | 562/562 (100 %) | 1 diff (99.9 %id) | ||
| DA686041 | .n | 11 to 546 | 2 to 538 | capped | 537/537 (100 %) | 2 diff (99.7 %id) | |||
| DB062819 | testis | .n | 31 to 565 | 2 to 537 | capped | 536/536 (100 %) | 6 diff (98.9 %id) | ||
| DB012078 | esophageal, tumor tissue | .n | 35 to 592 | 2 to 559 | capped | 558/558 (100 %) | 1 diff (99.9 %id) | ||
| DA524422 | brain | .n | 36 to 605 | 2 to 571 | capped | 570/570 (100 %) | 1 diff (99.9 %id) | ||
| BM764010 | myeloma | .n | 390 to 1089 | 1 to 700 | exact | tiling clone, | 700/700 (100 %) | 0 diff (100 %id) | |
| BM839816 | myeloma | .n | 390 to 945 | 1 to 556 | exact | 556/556 (100 %) | 0 diff (100 %id) | ||
| DA237895 | brain | .o-u | 1 to 584 | 2 to 584 | R2G L12G R13D Q14R G15V ... | tiling clone, capped | 583/583 (100 %) | 3 diff (99.5 %id) | |
| DB142912 | thymus | .o-u | 516 to 1073 | 2 to 559 | tiling clone, capped | 558/558 (100 %) | 1 diff (99.9 %id) | ||
| BG618208 | Liver | .p-u | 1 to 743 | 1 to 743 | exact | tiling clone, | 743/748 (99 %) | 7 diff (99.1 %id) | |
| AW268493 | pooled | .p-u | 559 to 1021 | 1 to 463 | tiling clone, | Submitted on the opposite strand | 463/463 (100 %) | 0 diff (100 %id) | |
| BG611437 | adenocarcinoma, Prostate | .q-u | 1 to 725 | 1 to 726 | H2I L3C L4G V5T H6F ... | tiling clone, | 726/726 (100 %) | 65 diff (91.1 %id) | |
| AA707597 | .q-u | 418 to 851 | 434 to 1 | exact | tiling clone, | 434/434 (100 %) | 2 diff (99.6 %id) | ||
| H95572 | liver and spleen | .q-u | 528 to 876 | 350 to 1 | exact | tiling clone, | 350/350 (100 %) | 1 diff (99.8 %id) | |
| DA181055 | amygdala | .r | 1 to 555 | 8 to 562 | tiling clone, capped | 555/555 (100 %) | 1 diff (99.9 %id) | ||
| CD706981 | normal nasopharynx | .r | 451 to 756 | 50 to 355 | tiling clone, | 306/355 (86 %) | 6 diff (98.4 %id) | ||
| CN301567 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .s | 1 to 737 | 1 to 738 | V2S | tiling clone, | 738/738 (100 %) | 3 diff (99.6 %id) | |
| DB111577 | thymus | .t | 1 to 561 | 5 to 565 | exact | tiling clone, capped | 564/564 (100 %) | 1 diff (99.9 %id) | |
| DB117664 | thymus | .u-u | 1 to 504 | 2 to 505 | exact | tiling clone, capped | 504/504 (100 %) | 0 diff (100 %id) |